Investigation reports an association between the fibrosis-4 index and adverse outcomes in hypertrophic cardiomyopathy, highlighting a potential link with chronic liver disease.
The fibrosis-4 index (FIB-4) is a non-invasive tool to assess fibrosis risk in chronic liver disease. We aimed to explore the relationship between the FIB-4 index and long-term major adverse cardiovascular events (MACE) in HCM patients.
No takes yet. Share an insight, caveat, or question.
Abdu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: